Targeting of anticancer drugs and genome medicine by utilizing absorption from the liver surface
Targeting of anticancer drugs and genome medicine by utilizing absorption from the liver surface
批准号:
14572033
负责人:
NISHIDA Koyo
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Development of drug delivery system to achieve site-specific delivery or prolonged retention in the circulation has attracted attention, because new types of drugs are expected to be created with advance in life science and biotechnology such as human genome project. We have tried to develop a new administration route for drug targeting to the liver, since normal drug administration by intravenous and oral route have difficulty in achieving a local site of action in the liver. As an anticancer model drug 5-fluorouracil (5-FU), we examined its hepatic disposition after application to the rat liver surface by employing a diffusion cell, and indicated the possibility for liver targeting. In addition, we suggested the novel application route to the other organ surfaces for genome medicine. Furthermore, we have examined the influence of liver disease on drug absorption from the liver surface membrane regarded as the first barrier for drug targeting to the liver. The main purpose of this study is to examine the possibility of direct liver surface application for drug targeting method. We employed rats intoxicated with carbon tetrachloride (CC14) or D-galactosamine (GAL) as the liver disease model, and examined drug absorption characteristics after application to the liver surface, by utilizing a cylindrical diffusion cell. In the liver-intoxicated rats, about 90 % of a low molecular weight drug phenolsulfonphthalein (PSP) as a model was absorbed from the liver surface in 6 h, similar to the normal rats (no treatment). Although the absorption rate was increased in the CC14 group whereas slightly retarded absorption was observed in GAL group, there should be no serious problem for clinical use of liver surface application. Consequently, it is expected that no marked decline in the absorption rate from liver surface in liver disease state and liver resection, leading to apply this administration method for liver targeting.
期刊论文(26)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Koyo Nishida: "Absorption characteristics of compounds with different molecular weights after application to the unilateral kidney surface in rats"European Journal of Pharmaceutics and Biopharmaceutics. 57(印刷中). (2004)
Koyo Nishida:“不同分子量化合物在大鼠单侧肾表面的吸收特性”,《欧洲药剂学和生物药剂学杂志》57(出版中)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Koyo Nishida: "Development of drug delivery system based on a new administration route for targeting to the specific region in the liver"YAKUGAKU ZASSHI. 123・8. 681-689 (2003)
Koyo Nishida:“基于针对肝脏特定区域的新给药途径的药物递送系统的开发”YAKUGAKU ZASSHI 123・8(2003)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Koyo Nishida: "Influence of liver disease on phenolsulfonphthalein absorption from liver surface to examine possibility of direct liver surface application for drug targeting"Biological & Pharmaceutical Bulletin. 26・7. 988-993 (2003)
Koyo Nishida:“肝脏疾病对肝脏表面酚磺酞吸收的影响,以检查直接肝脏表面应用药物靶向的可能性”26・7(2003)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Koyo Nishida: "Absorption of phenolsulfonphthalein as a model across the mesenteric surface in rats to determine the drug absorption route after intraperitoneal administration"Journal of Pharmacy and Pharmacology. 56(印刷中). (2004)
Koyo Nishida:“以大鼠肠系膜表面吸收酚磺酞为模型来确定腹膜内给药后的药物吸收途径”,《药学与药理学杂志》56(出版中)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Koyo Nishida: "Influence of liver disease on phenolsulfonphthalein absorption from liver surface to examine possibility of direct liver surface application for drug targeting"Biological & Pharmaceutical Bulletin. 26-7. 988-993 (2003)
Koyo Nishida:“肝脏疾病对肝脏表面酚磺酞吸收的影响,以检查直接肝脏表面应用药物靶向的可能性”生物
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 10 条
Development of two-layer sheet formulation to improve local disposition and therapeutic effect of anticancer drug
-
批准号:18K06598
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.83万
-
财政年份:2018
-
负责人:NISHIDA Koyo
-
依托单位:
Development of two-layer sheet formulation for application to liver surface to attain specific local chemotherapy
-
批准号:15K07891
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.16万
-
财政年份:2015
-
负责人:NISHIDA Koyo
-
依托单位:
Development of liver surface application formulation of anticancer drugs and gene medicine for clinical application
-
批准号:21590042
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.08万
-
财政年份:2009
-
负责人:NISHIDA Koyo
-
依托单位:
Development of formulation for liver surface application to control distribution and period of anticancer drugs and gene medicines
-
批准号:19590042
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.0万
-
财政年份:2007
-
负责人:NISHIDA Koyo
-
依托单位:
Development of liver surface application form of anticancer drugs and genome medicine aiming to specific therapy of the diseased region in the organ
-
批准号:16590029
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.37万
-
财政年份:2004
-
负责人:NISHIDA Koyo
-
依托单位:
海外基金